Himachal Pharma Sector Faces Major Trust Crisis
Himachal Pradesh's pharmaceutical hub is in turmoil as 38 firms lose WHO-GMP certification, raising serious quality concerns. Discover the causes and impact.
Himachal Pradesh's pharmaceutical hub is in turmoil as 38 firms lose WHO-GMP certification, raising serious quality concerns. Discover the causes and impact.
India mandates QR codes in all pharmacies for instant reporting of medicine side effects. This move aims to transform pharmacovigilance and make drug safety a public responsibility. Scan and report!
Bombay High Court directs a CDSCO expert committee to review Datar Cancer Genetics' plea for human trials of its Per-C-Vax cancer immunotherapy. The panel must submit its report within three months. Read the full details.
India's drug regulator CDSCO refuses to waive local trials for lenacapavir, blocking access to revolutionary HIV prevention for 25 lakh Indians. Learn why this happens despite drug being manufactured in India.
India's Health Ministry introduces landmark self-certification for low-risk medical devices, replacing complex licensing. This major reform aims to boost domestic manufacturing, reduce import dependency, and accelerate market access for MedTech innovators
Shocking details emerge as another baby dies after consuming Ayurvedic cough formulation in MP, raising serious questions about herbal medicine safety standards and regulation.
India's drug regulator CDSCO has flagged 112 medicines for quality violations and issued a nationwide alert about a spurious cough syrup following child fatalities in Madhya Pradesh. Critical safety update for consumers.
Leading pharmaceutical experts gathered in Chandigarh for a crucial conference on drug quality and regulatory compliance, focusing on improving manufacturing practices and patient safety across India.
World Health Organization reports India making progress on drug regulation but warns more action needed to prevent toxic cough syrup incidents that have claimed lives globally.